The latest closing stock price for Apellis Pharmaceuticals as of May 21, 2025 is 17.42.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $242 today, roughly 0 times their original investment - a 2.74% compound annual growth rate over 8 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 43.76, which is 151.2% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 16.10, which is 7.6% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 30.68.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $242 today, roughly 0 times their original investment - a 2.74% compound annual growth rate over 8 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 43.76, which is 151.2% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 16.10, which is 7.6% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 30.68.